VOTRIENT (pazopanib)


Votrient is used to treat adults with the following types of cancer:

• advanced renal cell carcinoma, a type of kidney cancer. It is used in patients who have not received any previous treatment or in patients who have already been treated for their advanced disease with anticancer medicines called ‘cytokines’. ‘Advanced’ means that the cancer has started to spread;

• certain forms of soft-tissue sarcoma, a type of cancer that develops from the soft, supporting tissues of the body. It is used in patients who have been previously treated with chemotherapy (medicines to treat cancer) because their cancer had spread, or in patients whose cancer has progressed within 12 months after receiving adjuvant or neoadjuvant therapy (treatment received after or before their main treatment).

Source: www.ema.europa.eu

Summary of the European Public Assessment Report (EPAR): 

Back to Catalogue of Drugs for Rare Diseases